Our recent collaboration with Massachusetts General Hospital (MGH) on the identification and validation of novel targets in Gram-negative bacteria is covered in the Spring edition of OneNucleus Newsletter. OneNucleus Spring.png

Read the full article on page 8 with our expert, Antonio Felici.